On a down day for U.S. stocks, even the latest rumor of a mega pharmaceuticals deal is proving ineffective in propping up exchange traded funds tracking the industry. Multiple media outlets are reporting that Israeli generic drug giant Teva Pharmaceuticals (NasdaqGS: TEVA) is mulling a bid for...